pI: 10.2911 |
Length (AA): 136 |
MW (Da): 15890 |
Paralog Number:
0
Signal peptide: Y | GPI Anchor: N | Predicted trans-membrane segments: 3
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 33 | 4tlm (A) | 798 | 827 | 23.00 | 0 | 0.01 | -0.0850059 | 3.83 |
12 | 78 | 3rko (M) | 118 | 194 | 33.00 | 0.07 | 0.04 | 0.348347 | 2.58 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, merozoite, early schizont, late schizont. | Otto TD PlasmoDB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 0 hs, gametocyte, sporozoite, early ring, early trophozoite, late ring, late trophozoite, Sporozoite. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, Ring, Female Gametocyte, Male Gametocyte. | Otto TD Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | Oocyst. | Zanghi G |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Ortholog group members (OG5_127881)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G03180 | Got1/Sft2-like vescicle transport protein |
Arabidopsis thaliana | AT5G01430 | Got1/Sft2-like vescicle transport protein |
Arabidopsis thaliana | AT1G05785 | Got1/Sft2-like vescicle transport protein |
Arabidopsis thaliana | AT3G49420 | Got1/Sft2-like vescicle transport-like protein |
Babesia bovis | BBOV_II003950 | CGI-141 protein-like protein, putative |
Babesia bovis | BBOV_II003960 | membrane protein, putative |
Brugia malayi | Bm1_54185 | UPF0198 protein CGI-141 homolog |
Candida albicans | CaO19.3972 | Golgi transport |
Candida albicans | CaO19.11455 | Golgi transport |
Caenorhabditis elegans | CELE_F41C3.4 | Protein F41C3.4 |
Cryptosporidium hominis | Chro.20025 | CGI-141 protein |
Cryptosporidium parvum | cgd2_190 | conserved hypothetical protein |
Dictyostelium discoideum | DDB_G0292868 | golgi transport protein 1 |
Drosophila melanogaster | Dmel_CG32576 | CG32576 gene product from transcript CG32576-RB |
Echinococcus granulosus | EgrG_000999400 | vesicle transport protein got1b |
Entamoeba histolytica | EHI_177450 | hypothetical protein, conserved |
Echinococcus multilocularis | EmuJ_000999400 | vesicle transport protein got1b |
Homo sapiens | ENSG00000111711 | golgi transport 1B |
Leishmania braziliensis | LbrM.18.1650 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_181610.1 | Got1/Sft2-like family, putative |
Leishmania infantum | LinJ.18.1610 | hypothetical protein, conserved |
Leishmania major | LmjF.18.1620 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.18.1620 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_09368 | hypothetical protein |
Mus musculus | ENSMUSG00000030245 | golgi transport 1 homolog B (S. cerevisiae) |
Neospora caninum | NCLIV_002290 | hypothetical protein |
Oryza sativa | 4329905 | Os02g0602800 |
Oryza sativa | 4343788 | Os07g0593400 |
Oryza sativa | 9271603 | Os10g0337600 |
Oryza sativa | 4332016 | Os03g0209400 |
Onchocerca volvulus | OVOC10905 | Putative Golgi transport protein 1 |
Plasmodium berghei | PBANKA_0721300 | protein transport protein GOT1, putative |
Plasmodium falciparum | PF3D7_0419200 | protein transport protein GOT1, putative |
Plasmodium knowlesi | PKNH_0511900 | protein transport protein GOT1, putative |
Plasmodium vivax | PVX_090050 | Got1 domain containing protein |
Plasmodium yoelii | PY07464 | hypothetical protein |
Saccharomyces cerevisiae | YMR292W | Got1p |
Schistosoma japonicum | Sjp_0083930 | Vesicle transport protein GOT1B, putative |
Schistosoma mansoni | Smp_166120 | hypothetical protein |
Schmidtea mediterranea | mk4.002413.01 | Probable Golgi transport protein 1 |
Trypanosoma brucei gambiense | Tbg972.10.14960 | predicted S. cerevisiae Got1 homologue |
Trypanosoma brucei | Tb927.10.12420 | predicted S. cerevisiae Got1 homologue |
Trypanosoma congolense | TcIL3000_10_10640 | predicted to be involved in ER-Golgi transport, putative |
Trypanosoma cruzi | TcCLB.507787.30 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.507625.160 | hypothetical protein, conserved |
Toxoplasma gondii | TGME49_295460 | Got1 family protein |
Theileria parva | TP04_0155 | hypothetical protein |
Trichomonas vaginalis | TVAG_375340 | Vesicle transport protein GOT1B, putative |
Trichomonas vaginalis | TVAG_177460 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_200610 | Vesicle transport protein GOT1B, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.12420 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.12420 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.12420 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.12420 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F41C3.4 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F41C3.4 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_F41C3.4 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_F41C3.4 | Caenorhabditis elegans | sterile | wormbase |
TGME49_295460 | Toxoplasma gondii | Probably non-essential | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.